COOKSON PEIRCE & CO INC

Position in BMY — Bristol Myers Squibb Co

CIK 1141455 PITTSBURGH, PA

Position in BMY

as of Mar 31, 2026 · filed Apr 30, 2026 Compact

Position Value

$577,327

-$149,145 QoQ

Shares Held

9,519

-16.2% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2022

7 quarters on record

Voting authority Sole 0.ToString("F0")% Shared 0.ToString("F0")% None 100.ToString("F0")%

Healthcare · as of Mar 31, 2026

COOKSON PEIRCE & CO INC holds $103,842,214 across 6 Drug Manufacturers - General names. BMY ranks #5 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	61,609	$56,666,109
2	NVS	Novartis AG	283,617	$43,322,496
3	AZN	Astrazeneca PLC	8,635	$1,702,994
4	GILD	Gilead Sciences, Inc.	8,663	$1,207,362
5	BMY	Bristol Myers Squibb Co This page	9,519	$577,327
6	JNJ	Johnson & Johnson	1,497	$365,926

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$577,327	9,519	-16.2%	Shares	Sole	2026-04-30
2023-06-30	$726,472	11,360	-90.7%	Shares	Sole	2023-08-01
2023-03-31	$8,497,683	122,604	+0.9%	Shares	Sole	2023-05-03
2022-12-31	$8,738,831	121,457	+512.2%	Shares	Sole	2023-01-31
2022-09-30	$1,410,496	19,841	+7.2%	Shares	Sole	2022-11-08
2022-06-30	$1,425,039	18,507	+173.6%	Shares	Sole	2022-07-20
2022-03-31	$493,974	6,764	—	Shares	Sole	2022-05-03
No filing history on record for this holder in this stock.